慢性高原病患者骨髓组织Bcl-2和Bcl-XL蛋白表达研究-内科学(血液病学)专业毕业论文.docxVIP

慢性高原病患者骨髓组织Bcl-2和Bcl-XL蛋白表达研究-内科学(血液病学)专业毕业论文.docx

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
青海大学 青海大学 2009 级高校教师在职攻读硕士学位论文 第 第 PAGE 3 页 共 35 页 Abstract Objective In the plateau region, chronic mountain sickness (CMS) is a common disease, is characterized by over-accumulation of red blood cells and serious hypoxemia. Its pathogenesis is complex. Studies confirmed that excessive proliferation of erythroblasts played an important role. However, the study on the apoptosis of hematopoietic cells is limited. Recent studies showed that the apoptosis of bone marrow hematopoietic cells is downregulated in CMS. Lots researches proved that Bcl-2 and Bcl-XL proteins of Bcl-2 family distributed widely on surface of hematopoietic stem cells and progenitors, and are key factors in determining the apoptosis change. The aim of this study is to observe the expressions of Bcl-2 and Bcl-XL in bone marrow tissue of patients with CMS, exploring their possible roles in the developing of CMS. Methods The CMS was diagnosed according to “Qinghai diagnostic criteria for chronic mountain sickness” (VI World Congress on Mountain Medicine and High Altitude Physiology). The bone marrow specimens were collected from 20 patients with CMS (CMS group) and 18 patients with simple orthopedics (Control group). They were all males. The average ages were 39.7±9.4 years old in CMS group and 40.5±10.8 years old in Control group. The expressions of Bcl-2 and Bcl-XL in bone marrow tissues were detected using the immunohistochemistry technique. These parameters mentioned above were compared between CMS group and Control group, and the correlations among Bcl-2, Bcl-XL proteins and hemoglobin (Hb) concentration were analyzed. Results The positive rates of Bcl-2 and Bcl-XL proteins in CMS patients were 75.00% and 85.00%, respectively, while were 27.78% and 33.33% in control group, respectively. In the positive rates of Bcl-2 and Bcl-XL between these two groups, There were significant differences (P<0.01). The positive coefficients of Bcl-2 and Bcl-XL proteins in CMS group were significantly higher

您可能关注的文档

文档评论(0)

peili2018 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档